Literature DB >> 1360938

Psychotic depression: advances in conceptualization and treatment.

S L Dubovsky1, M Thomas.   

Abstract

Psychotic depression is a unique subtype of depressive illness in which mood disturbance is accompanied by delusions, hallucinations, or both. Once considered relatively uncommon, it is frequently encountered in clinical practice, particularly in treatment-resistant depressed patients. Psychotically depressed patients respond poorly to antidepressants, but remission is likely with neuroleptic-antidepressant combinations or electroconvulsive therapy. Psychotic depression may be unipolar or bipolar with early or late onset and may be more likely to occur in patients with a history of childhood psychic trauma. Much is known about the course and treatment response of obvious presentations of psychotic depression, but more must be learned about depressed patients who have intermittent, subtle, or mild psychotic symptoms and about the ways in which the capacity to become psychotic interacts with the capacity to become depressed to produce a syndrome greater than the sum of its parts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360938     DOI: 10.1176/ps.43.12.1189

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  8 in total

1.  Atypical psychotic symptoms in a Hispanic population: diagnostic dilemmas and implications for treatment.

Authors:  David Mischoulon; Isabel T Lagomasino; Chris Harmon
Journal:  Psychiatry (Edgmont)       Date:  2005-10

2.  Mining mouse behavior for patterns predicting psychiatric drug classification.

Authors:  Neri Kafkafi; Cheryl L Mayo; Greg I Elmer
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

Review 3.  Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Authors:  B A Sproule; C A Naranjo; K E Brenmer; P C Hassan
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

4.  Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

Authors:  Shaul Schreiber; Avi Bleich; Chaim G Pick
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

5.  Mortality-causing mechanisms and healthcare resource utilisation of treatment-resistant depression: A six-year population-based cohort study.

Authors:  Vivien Ky Chan; Edmund Cl Cheung; Sandra Sm Chan; Martin Knapp; Joseph F Hayes; Min Fan; Francisco Tt Lai; Hao Luo; Terry Lum; Rosa Sm Wong; Lauren Kw Lau; Eric Yf Wan; Gloria Hy Wong; Esther Wy Chan; Patrick Ip; Ian Ck Wong; Xue Li
Journal:  Lancet Reg Health West Pac       Date:  2022-03-15

6.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

7.  Mood Disorders in Neurologic Illness.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

8.  Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression.

Authors:  Thaddeus Block; Georgios Petrides; Harvey Kushner; Ned Kalin; Joseph Belanoff; Alan Schatzberg
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.